CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis

Christine Caron1, Jonathan DeGeer2,3, Patrick Fournier1

  • 1CRCHUM - Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montréal, Québec, Canada.

Scientific Reports
|June 9, 2016
PubMed

Insights

CdGAP (cytoskeleton-associated Rho GTPase-activating protein) is crucial for embryonic vascular development. Its deficiency impairs blood vessel formation by disrupting VEGF signaling, leading to developmental defects and lethality.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Background:

  • Mutations in the CdGAP/ARHGAP31 gene are linked to Adams-Oliver syndrome, often involving vascular defects.
  • CdGAP is highly expressed in endothelial cells, but its role in vascular development was previously unknown.

Purpose of the Study:

  • To investigate the function of CdGAP in embryonic vascular development and its role in VEGF-mediated signaling.

Main Methods:

  • Utilized CdGAP-deficient mouse models (CdGAP-/-) and CdGAP knockdown in endothelial cells.
  • Assessed embryonic vascular development at E15.5, including vessel morphology and subcutaneous edema.
  • Examined VEGF-driven angiogenesis using aortic ring explants and endothelial cell migration assays.
  • Investigated the molecular mechanism by analyzing CdGAP interaction with VEGF receptor-2 and downstream signaling pathways (Rac1 activation, phosphorylation of Gab1, Akt, PLCγ, SHP2).

Main Results:

  • CdGAP deficiency in mice led to impaired vascular development, superficial vessel defects, subcutaneous edema, and 44% embryonic/perinatal lethality.
  • VEGF-driven angiogenesis, capillary sprouting, endothelial cell migration, and capillary formation were significantly reduced in CdGAP-deficient embryos and knockdown models.
  • CdGAP was found to associate with VEGF receptor-2, modulating VEGF-dependent signaling pathways.
  • CdGAP depletion resulted in impaired VEGF-mediated Rac1 activation and reduced phosphorylation of key signaling intermediates.

Conclusions:

  • CdGAP plays a critical role in embryonic vascular development and is essential for proper VEGF-induced signaling.
  • CdGAP acts as a key regulator of endothelial cell function in response to VEGF.
  • CdGAP represents a potential therapeutic target for pathological angiogenesis and vascular dysfunction.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K